Event

Free Webinar: How the MDR Impacts the QMS? Beyond the Obvious Aspects We Already Know.

September 08, 2020 - September 08, 2020 / Global

FREE WEBINAR | LIVE Q&A | LIMITED SPACE

Date: September 8th, 2020 

Time: 8:30am-10am PST | 11:30am-1pm EST

Location: Virtual

Language: English

Introduction

Most of manufacturers by now should already have learned and implemented many of the MDR QMS requirements, and have created procedures and templates to support the Post Market Surveillance, Post Market Clinical Follow up and Clinical Evaluation processes. For these examples of processes, the MDR has introduced very descriptive requirements for manufacturers to follow. But as we read the MDR carefully, we will learn that there are other processes that need to be addressed in the QMS. For these areas, the MDR provides the foundational regulatory requirements but may not explicitly state how the requirement can be addressed in the QMS or may not mention at all that these processes shall be covered in the manufacturer’s’ QMS. This webinar is intended to cover some of these areas that are not very obvious in the MDR, yet very crucial that manufacturers account for them in the QMS for MDR readiness.

 

Rania Gerges
Post date: June 29, 2020
Tags
How can we help you? Contact us